Lithium Carbonate Tablet
Product Images NDC 0054-8528

This is a description of the usual adult dose, storage requirements, and dispensing information for Lithium Carbonate Capsules USP by West-Ward Pharmaceuticals Corp. The usual adult dose is either 200 mg or 600 mg three times a day, and the medication should be stored at 20°C to 25°C with permitted temperature excursions to 157°C to 30°C. The capsules should be dispensed in a tight, child-resistant container and protected from moisture. Each capsule contains 150 mg lithium carbonate USP, and the accompanying Medication Guide should be dispensed to each patient.*

This is a description of a medication called Lithium Carbonate Capsules USP distributed by West-Ward Pharmaceuticals Corp., with each capsule containing 150mg of lithium carbonate. It comes in a non-child-resistant unit dose package and should only be dispensed for institutional use. The recommended adult dosage is 300mg or 600mg, three times a day. It should be stored at 20°C to 25°C and protected from moisture. The Pharmacist should provide a medication guide to each patient. For further information, refer to the package insert. The text ends with a product code number.*

This text contains information about a medication called Lithium Carbonate. It provides the usual adult dose, storage requirements, dispensing instructions, and prescription details. Each capsule contains 300 mg of lithium carbonate. It also mentions that a medication guide should be dispensed to each patient along with the medication.*

This is a medication information label for Lithium Carbonate tablets USP. The usual adult dose is 200 mg or 600 mg, to be taken three times a day. The tablets should be stored in a cool place at a temperature between 20°C to 25°C (68° to 77°F), with excursions permitted to 15°C to 30°C (50°F to 86°F) and should be kept in a tight, child-resistant container. The medication should be dispensed with an accompanying medication guide to each patient. Each tablet contains 300 mg of Lithium Carbonate, and the medication is distributed by West-Ward Pharmaceuticals Corp. The NDC for the medication is 0054-4527-25, and each bottle contains 100 tablets.*

Sz-2259-1500 is a Lithium Carbonate Capsules USP medication distributed by West-Ward Pharmaceuticals Corp. It comes in the form of a unit-dose package containing 10x10 capsules of 300mg lithium carbonate. The usual adult dose is either 300mg or 600mg three times a day. This medication guide should be dispensed to each patient by the pharmacist. The package is not child-resistant, so a child-resistant container should be used for outpatient use. The medication should be stored between 20° to 25°C but can be kept within 15° to 30°C. For more information, see the package insert for complete prescribing information.*

This is a medication information sheet for Lithium Carbonate Tablets distributed by West-Ward Pharmaceuticals, for institutional use only. Each tablet contains 300mg of Lithium Carbonate USP, and the usual adult dose is 300mg or 600mg three times a day. The package insert should be consulted for complete prescribing information. The tablets should be stored at room temperature and protected from moisture. The package is not child-resistant, so a child-resistant container should be used if dispensed for outpatient use. A medication guide is enclosed and should be given to each patient.*

This is a medication package of Lithium Carbonate Capsules with the National Drug Code 0054-2531-25. Each capsule contains 600 mg lithium carbonat:e USP, and the usual adult dose is 300 mg or 600 mg three times a day. The pharmacist should dispense the accompanying Medication Guide to each patient, and patients should see the Package Insert for Complete Prescribing Information. The medicine is distributed by West-Ward Pharmaceuticals Corp, and it should be stored in a place protected from moisture and at room temperature.*

This is a pharmaceutical product distributed by West-Ward Pharmaceuticals Corp. It is a Lithium Carbonate Capsule USP and it contains 600 mg. The recommended dosage is 300 mg or 600 mg three times a day. There is an enclosed medication guide that should be distributed to each patient. This unit-dose package is not child-resistant, so if it is dispensed for outpatient use, a child-resistant container should be utilized. It is for institutional use only and should be stored at 20-25°C (68-77°F) with protection from moisture.*

This is a medication guide for Lithium oral solution. Each 5 mL contains 8 mEq of Lithium Ion USP which is equivalent to 200 mg of lithium carbonate. This solution is alcohol-free and sugar-free and must be dispensed in a tight, child-resistant container. The recommended adult dosage is 5 to 10 mL (8-16 mEq of lithium) three times a day. The medication guide should be provided to each patient. The solution should be stored at 20° to 25°C (68° to 77°F), and the excursions are permitted to 15° to 30°C (59° to 86°F). For complete prescribing information, refer to the package insert. The distributor of this medication is West-Ward Pharmaceuticals Corp, located in Eatontown, NJ 07724, which is a HIKMA company.*